Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-β1 by neutrophils: Role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I

Transfusion

Volumn 47, Issue 8, 2007, Pages 1395-1404

  Ottonello, Luciano ^a   Ghio, Massimo ^b   Contini, Paola ^b   Bertolotto, Maria ^b   Bianchi, Giordano ^b   Montecucco, Fabrizio ^b   Colonna, Marco ^b   Mazzei, Clemente ^b   Dallegri, Franco ^b   Indiveri, Franco ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; HLA ANTIGEN CLASS 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD SAMPLING; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; IN VIVO STUDY; MALE; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN;

ANTIGENS, CD; CHEMOTAXIS, LEUKOCYTE; ERYTHROCYTE TRANSFUSION; FAS LIGAND PROTEIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; NEUTROPHILS; RECEPTORS, IMMUNOLOGIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34547092150     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01268.x     Document Type: Article

References (46)

1. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine: second of two parts - blood conservation. N Engl J Med 1999 340 : 525 33.
2. Chelemer SB, Prato BS, Cox PM Jr., et al. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002 73 : 138 42.
3. Hill GE, Frawley WH, Griffith KE, et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003 54 : 908 14.
4. Houbiers JG, van de Velde CJ, van de Watering LM, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997 37 : 126 34.
5. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion 1999 39 : 701 10.
6. Vamvakas E, Dzik W, Blajchman M. Deleterious effects of transfusion-associated immunomodulation: appraisal of the evidence and recommendations for prevention. In : Vamvakas E, Blajchman M, editors. Immunomodulatory effects of blood transfusion. Bethesda : American Association of Blood Banks 1999. p. 2 53 85.
7. Rouger P. Transfusion induced immunomodulation: myth or reality? Transfus Clin Biol 2004 11 : 115 6.
8. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 2005 45 (2 Suppl 33S 9S discussion 9S 40S.
9. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001 97 : 1180 95.
10. Lehrer RI, Ganz T, Selsted ME, et al. Neutrophils and host defense. Ann Intern Med 1988 109 : 127 42.
11. Ghio M, Ottonello L, Contini P, et al. Transforming growth factor-beta1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Blood 2003 102 : 1100 7.
12. Nakajima H, Samaridis J, Angman L, Colonna M. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. J Immunol 1999 162 : 5 8.
13. Puppo F, Contini P, Ghio M, et al. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes. Int Immunol 2000 12 : 195 203.
14. Ottonello L, Tortolina G, Amelotti M, Dallegri F. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J Immunol 1999 162 : 3601 6.
15. Ottonello L, Frumento G, Arduino N, et al. Differential regulation of spontaneous and immune complex-induced neutrophil apoptosis by proinflammatory cytokines: role of oxidants, Bax and caspase-3. J Leukoc Biol 2002 72 : 125 32.
16. Ghio M, Contini P, Mazzei C, et al. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 1999 93 : 1770 7.
17. Andre P, Biassoni R, Colonna M, et al. New nomenclature for MHC receptors. Nat Immunol 2001 2 : 661.
18. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973 5 : 253 9.
19. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther 2002 9 : 389 95.
20. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004 21 : 137 48.
21. Beutler B. Innate immunity: an overview. Mol Immunol 2004 40 : 845 59.
22. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion- associated postoperative infection. Transfus Med Rev 2002 16 : 144 60.
23. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992 79 : 513 6.
24. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994 84 : 1703 21.
25. Li MO, Wan YY, Sanjabi S, et al. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006 24 : 99 146.
26. Bachman KE, Park BH. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol 2005 17 : 49 54.
27. Oft M, Heider KH, Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998 8 : 1243 52.
28. Broderick L, Bankert RB. Membrane-associated TGF-beta1 inhibits human memory T cell signaling in malignant and nonmalignant inflammatory microenvironments. J Immunol 2006 177 : 3082 8.
29. Ghiringhelli F, Puig PE, Roux S, et al. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med 2005 202 : 919 29.
30. Ghiringhelli F, Menard C, Terme M, et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 2005 202 : 1075 85.
31. Busch OR, Hop WC, Hoynck van Papendrecht MA, et al. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993 328 : 1372 6.
32. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993 342 : 1328 33.
33. Wajant H, Pfizenmaier K, Scheurich P. Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 2003 14 : 53 66.
34. Hohlbaum AM, Gregory MS, Ju ST, Marshak-Rothstein A. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol 2001 167 : 6217 24.
35. Park DR, Thomsen AR, Frevert CW, et al. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol 2003 170 : 6209 16.
36. Guo Z, Zhang M, Tang H, Cao X. Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. Blood 2005 106 : 2033 41.
37. Gunturi A, Berg RE, Forman J. The role of CD94/NKG2 in innate and adaptive immunity. Immunol Res 2004 30 : 29 34.
38. Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 2004 16 : 626 33.
39. Colonna M, Nakajima H, Navarro F, Lopez-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 1999 66 : 375 81.
40. Gessner JE, Heiken H, Tamm A, Schmidt RE. The IgG Fc receptor family. Ann Hematol 1998 76 : 231 48.
41. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001 19 : 275 90.
42. van Sorge NM, van der Pol WL, van de Winkel JG. FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 2003 61 : 189 202.
43. Ashtekar AR, Saha B. Poly's plea: membership to the club of APCs. Trends Immunol 2003 24 : 485 90.
44. Bennouna S, Bliss SK, Curiel TJ, Denkers EY. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J Immunol 2003 171 : 6052 8.
45. Daley JM, Reichner JS, Mahoney EJ, et al. Modulation of macrophage phenotype by soluble product(s) released from neutrophils. J Immunol 2005 174 : 2265 72.
46. Scapini P, Lapinet-Vera JA, Gasperini S, et al. The neutrophil as a cellular source of chemokines. Immunol Rev 2000 177 : 195 203.